Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T, Chaiyawat P, Netsirisawan P, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J, Champattanachai V*.
Oncol Rep. 2013 Dec;30(6):2929-36.
To find the 2nd edition, type "2nd edition"
Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T, Chaiyawat P, Netsirisawan P, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J, Champattanachai V*.
Oncol Rep. 2013 Dec;30(6):2929-36.
Chanthammachat P, Promwikorn W, Pruegsanusak K, Roytrakul S, Srisomsap C, Chokchaichamnankit D, Svasti J, Boonyaphiphat P, K S, Thongsuksai P*.
Arch Oral Biol. 2013 Nov;58(11):1677-85.
Proteomic analysis reveals important role of 14-3-3σ in anoikis resistance of cholangiocarcinoma cells.
Khongmanee A, Lirdprapamongkol K, Tit-Oon P, Chokchaichamnankit D, Svasti J, Srisomsap C*.
Proteomics. 2013 Nov;13(21):3157-66.
A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells.
Lirdprapamongkol K*, Sakurai H, Abdelhamed S, Yokoyama S, Maruyama T, Athikomkulchai S, Viriyaroj A, Awale S, Yagita H, Ruchirawat S, Svasti J, Saiki I.
Oncol Rep. 2013 Nov;30(5):2357-64.
Pansanit A, Park EJ, Kondratyuk TP, Pezzuto JM, Lirdprapamongkol K, Kittakoop P*.
J Nat Prod. 2013 Sep 27;76(9):1824-7.